Latest Operational Impact News

Page 2 of 11
ReNerve has appointed J4 Biologics as a second manufacturer for its Empliq range to meet growing hospital approvals and market demand, strengthening its supply chain and scaling production capacity.
Ada Torres
Ada Torres
11 June 2026
Amaero Ltd has obtained Federal Court approval to re-domicile to Delaware via schemes exchanging Australian shares and options for US HoldCo equivalents, marking a major structural shift.
Victor Sage
Victor Sage
10 June 2026
Antilles Gold’s Cuban joint venture Minera La Victoria has been hit with US sanctions, prompting a suspension of the company’s direct involvement and halting trading of its shares and options.
Maxwell Dee
Maxwell Dee
10 June 2026
Amaero Ltd secured strong shareholder approval for its US re-domiciliation schemes and a director option grant at virtual meetings held on 5 June 2026.
Victor Sage
Victor Sage
5 June 2026
XPON Technologies is shedding Alpha Digital after just over a year, in a move that clears the way for a tighter AI-centric growth strategy. The deal involves significant debt forgiveness, reflecting a clean break from a services-led business that once contributed over a third of group revenue.
Sophie Babbage
Sophie Babbage
3 June 2026
Nexalis Therapeutics has locked in a $53 million non-dilutive funding facility with Point8 Capital, replacing its previous lender and supporting three clinical programs targeting breakthrough cancer pain, panic disorder, and treatment-resistant depression.
Ada Torres
Ada Torres
28 May 2026
Australian Dairy Nutritionals has closed the gap on its recent Entitlement Offer by placing 25 million shortfall shares, raising an additional $0.7 million and bringing total proceeds to $1.2 million.
Victor Sage
Victor Sage
15 May 2026
ALS Limited has detected a malicious cyber attack that temporarily disrupted parts of its operations. The company is actively investigating the incident and working with authorities while restoring affected systems.
Victor Sage
Victor Sage
5 May 2026
Little Green Pharma (ASX:LGP) posted record quarterly and annual revenues driven by a surge in European sales, improved cashflow, and reduced debt. The company is on track to complete its merger with Cannatrek by June 1, 2026, while benefiting from the US rescheduling of medicinal cannabis to Schedule III.
Ada Torres
Ada Torres
30 Apr 2026
Alara Resources maintained steady copper-gold production at its Al Wash-hi Majaza Mine despite regional geopolitical shipping disruptions, while advancing exploration and managing ongoing legal proceedings in Oman.
Maxwell Dee
Maxwell Dee
30 Apr 2026
Trade Window Holdings has announced the unexpected resignation of founding CEO AJ Smith due to illness, with COO Dewald van Rensburg stepping in as acting CEO. The board is currently evaluating options for a permanent replacement.
Sophie Babbage
Sophie Babbage
20 Apr 2026
Carbonxt Group has secured $750,000 through convertible notes from major shareholder Phelbe Pty Ltd, targeting expansion of its Minnesota pellet manufacturing and increasing its New Carbon Processing stake to 48.1%.
Victor Sage
Victor Sage
16 Apr 2026

Browse the archive

Full archive